Luigi Lavazza SpA is studying a tie-up with Germany’s Dallmayr as the coffee industry remains under pressure due to surging prices, Corriere della Sera reported on Saturday, without saying where ...

The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV treatments due to low levels of a type of white blood cell in some ...

Key takeaways: The addition of relacorilant to nab-paclitaxel reduced risk for progression or death by 30% among women with platinum-resistant disease. The combination is a potential new standard ...

Combination therapy can prolong life in severe heart disease Aortic stenosis and concomitant cardiac amyloidosis should be treated together Date: June 2, 2025 Source: Medical University of Vienna ...

In mice, the combination therapy not only improved the health of aging mice, but also extended their lifespan by around 30 percent.

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate to wait for efficacy data from a late-stage trial of its influenza ...

The combination of common stock will not eliminate any shareholders of record since any fractional share resulting from the combination of common stock will be rounded to the nearest whole share.

While no combination creates truly “instant” weight loss in literal terms, these synergistic pairings establish the metabolic conditions for maximal fat utilization from the very first meal.

FASB published an Accounting Standards Update that is intended to improve the requirements for identifying the accounting acquirer in FASB ASC Topic 805, Business Combinations.

Discover fruit combinations that might lead to bloating, acid reflux or digestive discomfort, plus learn the science behind food combining for better gut health ...

Despite several randomized controlled trials demonstrating the benefits of combination therapies for metastatic hormone-sensitive prostate cancer (mHSPC), a significant treatment gap persists. This ...

Neoadjuvant combination immunotherapy may improve survival compared with single-agent therapy for patients with head and neck squamous cell carcinoma, according to results of a randomized phase 2 ...